B.C. Ltd. ("131"), 16796788 Canada Ltd. ("Subco") and Britannia Mining Solutions Inc. ("Britannia") are pleased to announce that further to the non-binding letter of intent dated January 22, 2025, 131 ...
Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback